Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis

por Dholakia, Jhalak, Cohn, David E., Straughn, J Michael, Dilley, Sarah E.
Publicado 2021

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

por Smith, Haller J., Straughn, J. Michael, Buchsbaum, Donald J., Arend, Rebecca C.
Publicado 2017

Beyond words: Parental perceptions on human papilloma virus vaccination recommendations and its impact on uptake

por Boitano, Teresa K.L., Daniel, Casey, Kim, Young-il, Straughn, J. Michael, Peral, Sylvia, Scarinci, Isabel
Publicado 2021

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab

por Meredith, Ruby F., Torgue, Julien J., Rozgaja, Tania A., Banaga, Eileen P., Bunch, Patty W., Alvarez, Ronald D., Straughn, J. Michael, Dobelbower, Michael C., Lowy, Andrew M.
Publicado 2018

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth

por Turner, Taylor B, Meza-Perez, Selene, Londoño, Angelina, Katre, Ashwini, Peabody, Jacelyn E., Smith, Haller J., Forero, Andres, Norian, Lyse A, Straughn, J. Michael, Buchsbaum, Donald J., Rand all, Troy D., Arend, Rebecca C.
Publicado 2017